Thank you for joining Collaborating for a Cure,
the SRF Patient Forum
An online event for people living with scleroderma and those who care about them.
Watch the 2023 Patient Forum on YouTube
“Collaborating for a Cure” is an online, half-day forum hosted by the Scleroderma Research Foundation that anyone can attend for FREE. This year, “Collaborating for a Cure” was held on June 6, 2023 at 9:00 am PDT/12:00 pm EDT to as part of our efforts for Scleroderma Awareness Month.
The forum features educational sessions on symptom management, new developments in research, and your role in finding a cure for scleroderma:
-
Informative sessions presented by leaders in the field of scleroderma research and medicine
-
Live Q&A following each presentation
-
Interactive games and activities to win prizes

The SRF Forum, Scleroderma Awareness Month, and YOU
Because of our singular focus on understanding scleroderma, the SRF has the most up-to-date and relevant information about complications, treatments, and related research. Everyone should have access to this information. That’s why we created the SRF Patient Forum as a part of our efforts for Scleroderma Awareness Month—so that you’re armed with the most relevant facts about scleroderma, all while the search for a cure continues.
Spread the word by sharing what you’ve learned or your story, using #SayScleroderma on social media during Scleroderma Awareness month and beyond.
Watch the Sessions from the 2022 Forum
What You Need to Know about Systemic Sclerosis and Research
GI Involvement in Systemic Sclerosis
Genomics Sessions
Collaborating for a Cure – The SRF Cure Crew
The CONQUER Registry
Advances in Pulmonary Arterial Hypertension Research
Fibrotic Lung Disease in System Sclerosis
Thank you to our generous industry partners for sponsoring the SRF Patient Forum.
Diamond Sponsors


Platinum Sponsor

Silver Sponsor

Interested in becoming a sponsor?
For more information contact Gloria Blecha, Senior Director of Community Outreach and Education, at gloria@sclerodermaresearch.org.